Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Michelle Obama has left a very important legacy in the United States, especially in the health sector with medical care and ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

In his testimony this week, Kennedy claimed that infectious diseases receive far more federal funding than chronic diseases.

Young boys who ate a greater proportion of ultraprocessed foods were more likely to develop overweight or obesity by age 5 years, according to findings published in JAMA Network Open.“Ultraprocessed ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

Police boats have returned to the Potomac River as part of the recovery and investigation after the United States’ deadliest ...

Rep. Chip Roy (R-TX) issued a diagnosis for America’s broken health care system, and the congressman says the problem isn’t what people think.

Republicans want to ban the use of federal Supplemental Nutrition Assistance Program funds to purchase candy and soda.

The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.